← FDA DRUG APPROVALS

FDA ANDA · ANDA216678

CHLORPROMAZINE HYDROCHLORIDE

Sponsor: RUBICON RESEARCH

APPLICATION
ANDA216678
TYPE
ANDA
ORIGINAL APPROVAL
2025-10-10
LATEST ACTION
2025-10-10
ROUTE
ORAL
DOSAGE FORM
CONCENTRATE
MARKETING STATUS
Prescription

Products

CHLORPROMAZINE HYDROCHLORIDEPrescription
CHLORPROMAZINE HYDROCHLORIDE 30MG/ML · CONCENTRATE · ORAL
CHLORPROMAZINE HYDROCHLORIDEPrescription
CHLORPROMAZINE HYDROCHLORIDE 100MG/ML · CONCENTRATE · ORAL

Approval history

2025-10-10UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →